Third Qatar Diabetes and Obesity Research Symposium

​Third Qatar Diabetes and Obesity Research Symposium

(Thursday, 2 May 2024, from 7:00 am to 02:50 pm)

At Sheraton Grand Doha Resort and Convention Center


Hybrid program​

Activity Date:  May 2-4, 2024

Venue: Sheraton Grand Doha Resort & Convention Center

Activity Code: HGI-02-MED-P985.

Activity Type: Category 1

Target Audience: Physicians, nurses, allied health professionals, pharmacists, and researchers

Overall Learning Outcome:

  • To provide an expert forum to share knowledge, updates, and developments in the clinical and scientific field of diabetes, obesity, and endocrinology.
  • To provide a platform for knowledge exchange of key disciplines and sub-specialties where relevant to endocrinology, diabetes, obesity, and metabolic diseases.
  • To facilitate scientific exchange, interactions, and collaborations at national and international level among researchers, scientists, and practitioners.

7.00-7.45am

Registration and Coffee

7.45-8.00am

Welcome Address

Prof. Shahrad Taheri, Chair of the Diabetes Research Sub-Committee, National Diabetes Strategy

8.00-8.10am

Opening Remarks

Dr. Sheikh Mohamed Al -Thani, Director, Non-Communicable Diseases Prevention Programs, Ministry of Public Health (MoPH)

8.10-8.50am

Kisspeptin and its Role in Physiology and Disease

Dr. Ali Abbara, Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Clinical Senior Lecturer in Diabetes and Endocrinology, Imperial College London, UK

Learning Objective:Explore the Mechanism of Action and Evaluate the Potential Therapeutic Applications of Kisspeptin Across Diverse Medical Conditions.

8.50-9.10am

National STEPWise Survey on Non-Communicable Diseases

Dr. Sheikh Mohamed Al -Thani, Director, Non-Communicable Diseases Prevention Programs, Ministry of Public Health (MoPH)

Learning Objective:Introduce the Preliminary Finding of the 2023 Qatar National STEPWise Survey

9.10-9.30am

Coffee Break

Session 1 – Type 1 Diabetes Research

Learning Objective: Gain Insights into Current Advances in Research on Type 1 Diabetes (T1D) Pathogenesis, Screening, Monitoring, and Management.

Moderators

Dr. Dabia Al-Mohanadi

Sr. Consultant, Endocrinology, Division Head of Endocrinology, Deputy Director of Qatar Metabolic Institute (QMI), Assistant Chair for Education - Department of Medicine, Hamad Medical Corporation (HMC)

Dr. Mohamed Aghar Elrayess

Director of Basic Research, Health Sector, Qatar University (QU)

9.30-10.10am

Type 1 Diabetes Immunology

Prof. Parth Narendran, Professor of Diabetes Medicine, Honorary Consultant Physician, Institute of Immunology and Immunotherapy, University of Birmingham, UK

10.10-10.30am

Automated Insulin Delivery for Safe Fasting and Exercise During Ramadan in T1DM

Dr. Khaled Baagar,Consultant Endocrinologist, Hamad Medical Corporation (HMC)

10.30-10.50am

DIA-MENA: Type 1 Diabetes Islet Autoantibody Screening Initiative in the Middle East and North Africa

Dr. Ammira Al-Shabeeb Akil, Principal Investigator, Genetics and Metabolic Disorders Program Lead, Head, Precision Medicine of Diabetes Prevention laboratory, Sidra Medicine

Session 2 – Obesity Research

Learning Objective: Understand Interventions and Therapeutic Targets in Obesity Management and Care

Moderators

Dr. Tariq Chukir

Assistant Professor of Medicine, Weill Cornell Medicine-Qatar (WCM-Q)

Dr. Kholoud Al Mutawaa

Co-Chair, National Diabetes Committee, Ministry of Public Health (MoPH)

10.50-11.30am

Interventions to Prevent Obesity through Maternal Health

Prof. Jodie Dodd, Professor Obstetrics and Gynaecology, University of Adelaide, Robinson Institute, Australia

11.30-11.50am

Endocannabinoid System as Targets for Obesity Treatment

Dr. Abdella Mohammed Habib, Assistant Professor of Biochemistry, Qatar University (QU)

11.50am-12.10pm

Prayer time and Coffee

Session 3 – New Discoveries

Learning Objective: Explore Precision Medicine, and Emerging Concepts in Diabetes and Obesity Research

Moderators

Prof. Shahrad Taheri,

Chair of the Diabetes Research Sub-Committee, National Diabetes Strategy

Dr. Abdelilah Arredouani

Senior Scientist, Diabetes Research Center, Qatar Biomedical Research Institute (QBRI), Associate Professor, College of Health & Life Science, Hamad Bin Khalifa University (HBKU)

12.10-12.50pm

Precision Bariatric Surgery

Prof. Francois Pattou, Professor of Surgery, Faculty of Medicine, Lille University, France

Young Researchers’ Presentations

12.50-1.00pm

Covid-19 and Obesity – Survey Data

Ms. Hawra Al-Saygh, Clinical Research Officer,Hamad Medical Corporation (HMC)

1.00-1.10pm

Early Corneal Nerve Loss in Children with Obesity and Diabetes

Dr. Hoda Gad, Clinical Research Specialist Weill Cornell Medicine-Qatar (WCM-Q)

1.10-1.20pm

Investigating Molecular Pathways of Cellular Senescence in Preadipocytes

Dr. Aisha Madani, Postdoctoral Associate in Microbiology and Immunology, Weill Cornell Medicine-Qatar (WCM-Q)

1.20-1.30pm

Enhanced Generation of Functional Stem Cell-Derived Pancreatic Beta Cells

Dr. Idil Ahmed, Postdoctoral Fellow, Sidra Medicine

1.30-1.40pm

The Metabolic Switch of Physical Activity in Non-Obese Insulin Resistant Individuals

Ms. Shamma Almuraikhy, Senior Research Assistant, Qatar University (QU)

1.40-1.50pm

UHRF1, an E3 Ubiquitin-Protease Ligase, Regulates Adipogenesis in Preadipocytes

Dr. Muneera Vakayil, Postdoctoral Associate in Microbiology & Immunology, Weill Cornell Medicine-Qatar (WCM-Q)

1.50-2.00pm

Q&A

2.00-2.40pm

Genetics of Type 2 Diabetes

Prof. Inga Prokopenko, Professor e-One Health and Head of Statistical Multi-Omics, Academic and Research Department, University of Surrey, UK

2.40-2.50pm

Discussion – Reflections

Prof. Shahrad Taheri, Chair of the Diabetes Research Sub-Committee, National Diabetes Strategy

2.50-3:30pm

Lunch


 


This activity is an Accredited Group Learning Activity Category 1 as defined by the Ministry of Public Health’s Department of Healthcare Professions - Accreditation Section and is approved for a maximum of 18 hours.

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators, and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.​​